Jason Dussault - Goodbody Health Co IR
Insider
Jason Dussault is Co IR of Goodbody Health
Age | 49 |
Web | https://www.goodbodyhealth.com |
Goodbody Health Management Efficiency
The company has return on total asset (ROA) of (0.1333) % which means that it has lost $0.1333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5554) %, meaning that it generated substantial loss on money invested by shareholders. Goodbody Health's management efficiency ratios could be used to measure how well Goodbody Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Zohar Krivorot | Cannara Biotech | 46 | |
Mba BEcon | Avicanna | N/A | |
Friederike Rotsch | MERCK Kommanditgesellschaft auf | 51 | |
Peter Guenter | Merck KGaA ADR | 61 | |
Brian Sherman | Cannara Biotech | N/A | |
David Abitbol | Cannara Biotech | N/A | |
Carlos Muete | Avicanna | N/A | |
Julia Bouvet | Cannara Biotech | N/A | |
Gerhard Schmitz | Merck KGaA ADR | 60 | |
Alexander Wolfe | Cannara Biotech | N/A | |
Peter Guenter | MERCK Kommanditgesellschaft auf | 61 | |
Belen MD | Merck KGaA ADR | 63 | |
Matthias Heinzel | MERCK Kommanditgesellschaft auf | 56 | |
Etienne Ledoux | Cannara Biotech | N/A | |
Dirk Toepfer | Merck KGaA ADR | N/A | |
France Landry | Cannara Biotech | N/A | |
Barbara Weiland | Merck KGaA ADR | 49 | |
Caitlin Johnston | Avicanna | N/A | |
Roland Alvarez | Avicanna | N/A | |
Barbara Weiland | MERCK Kommanditgesellschaft auf | 49 | |
Dirk Toepfer | MERCK Kommanditgesellschaft auf | N/A |
Management Performance
Return On Equity | -0.56 | |||
Return On Asset | -0.13 |
Goodbody Health Leadership Team
Elected by the shareholders, the Goodbody Health's board of directors comprises two types of representatives: Goodbody Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Goodbody. The board's role is to monitor Goodbody Health's management team and ensure that shareholders' interests are well served. Goodbody Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Goodbody Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
FCCA ACIS, Company CFO | ||
Emily Critchley, Group HR | ||
George Thomas, Chief Director | ||
Krzysztof Wojtanowski, Head Poland | ||
Marc Howells, CEO Director | ||
Julia Edwards, Group Marketing | ||
Jason Dussault, Co IR |
Goodbody Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Goodbody Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.56 | |||
Return On Asset | -0.13 | |||
Profit Margin | (0.23) % | |||
Operating Margin | (0.11) % | |||
Current Valuation | (884.3 K) | |||
Shares Outstanding | 36.5 M | |||
Shares Owned By Insiders | 2.09 % | |||
Shares Owned By Institutions | 0.01 % | |||
Price To Book | 0.16 X | |||
Price To Sales | 0.15 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Goodbody OTC Stock
Goodbody Health financial ratios help investors to determine whether Goodbody OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goodbody with respect to the benefits of owning Goodbody Health security.